Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: A randomized clinical trial
- 1 April 1985
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 14 (3), 222-228
- https://doi.org/10.1007/bf00258120
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancerGynecologic Oncology, 1983
- Second-look operations in the planned management of advanced ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1982
- Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.1982
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- ADVANCED OVARIAN-CANCER - BRIEF INTENSIVE COMBINATION CHEMOTHERAPY AND 2ND-LOOK OPERATION1981
- Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study.1980
- Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.1979
- Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.1979
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- The Enhanced Therapeutic Effect of cis-Platinum (II) Diamminodichloride against L1210 Leukemia when Combined with Cyclophosphamide or 1,2-bis(3,5-Dioxopiperazine-1-yl)propane or Several other Antitumor AgentsChemotherapy, 1973